Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Añadir filtros








Tipo de estudio
Intervalo de año
3.
Saudi Medical Journal. 2003; 24 (12): 1360-3
en Inglés | IMEMR | ID: emr-64510

RESUMEN

To identify the cause, methods of diagnosis and management of malignant biliary strictures in our institution and compare with studies from other communities. From March 1998 through to August 2002, we reviewed 1000 files of patients who underwent endoscopic retrograde cholangiopancreatography [ERCP] at the Gastroenterology unit, King Khalid University Hospital in Riyadh, Kingdom of Saudi Arabia for malignant biliary strictures [MBS]. Clinical, laboratory data, method of diagnosis and management were recorded. Seventy-two patients [72/1000] with MBS were encountered. Forty one [57%] were males and 31 [43%] were females and the majority were Saudi nationals [82%]. Jaundice and right upper quadrant pain were the most frequent symptoms in 84.7% and 52.8% of patients. Cholangiocarcinoma was present in 31 [43%] and pancreatic adenocarcinoma in 23 [31.9%] patients. Other malignancies found included gallbladder carcinoma in 5 patients [6.9%], ampullary carcinoma in 5 [6.9%], metastatic liver carcinoma in 4 patients [5.6%], hepatocellular carcinoma in 2 [2.8%] and lymphoma in 2 [2.8%]. The diagnosis was entertained mainly by ERCP [93%]. Endoscopic palliation was carried out in 77.8% of patients, percutaneous transhepatic drainage in 13.9% and surgery in 6 [8.3%]. The mean survival was higher for the endoscopic compared to the percutaneous transhepatic and surgery groups [6.9 +/- 4.13, 4.27 +/- 4.29 and 3.67 +/- 2.65 months]. In non-resectable tumors, ERCP is the optimal method of diagnosis and palliation of MBS


Asunto(s)
Humanos , Masculino , Femenino , Colangiocarcinoma , Neoplasias Pancreáticas , Neoplasias de la Vesícula Biliar , Neoplasias Hepáticas , Carcinoma Hepatocelular , Linfoma , Colangiopancreatografia Retrógrada Endoscópica , Manejo de la Enfermedad
4.
Saudi Medical Journal. 2003; 24 (12): 1370-3
en Inglés | IMEMR | ID: emr-64512

RESUMEN

It has been suggested from previous studies that there is an associated increased risk of coronary artery disease [CAD] in patients with Helicobacter pylori [H.pylori]. However, others dispute this. We therefore evaluated this hypothesis in a group of patients with confirmed H.pylori infection. A total of 158 patients with dyspeptic symptoms were evaluated by esophago-gastro-duodenoscopy [EGD] in King Khalid University Hospital in Riyadh, Kingdom of Saudi Arabia from May through to June 1997. Endoscopic biopsies and histology as well as culture and serology for H.pylori were obtained. In patients with confirmed H.pylori a further analysis was performed looking at associated [CAD] or known risk factors for CAD. Among the 158 patients who underwent EGD, 143 patients [90.5%] were found to have H.pylori either by culture, histology or serology, or both in a percentage of [31.5%] [77.6%] and [60.8%]. There was no evidence of CAD in this group of patients based on history, electrocardiogram [ECG], echocardiography, ECG stress test, dypiridamole thallium scan or coronary angiography. Other known risk factors for CAD were cigarette smoking [12.6%], diabetes mellitus [10.5%], hypertension [1.4%] and hyperlipidemia [2.8%]. Helicobacter pylori infection does not increase the risk of CAD, and should not be considered as an independent risk factor for CAD. Further, prospective large trial is needed to confirm our finding


Asunto(s)
Humanos , Masculino , Femenino , Infecciones por Helicobacter , Helicobacter pylori , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA